,CHAF1A

Jiajing Li1, Ting Zhang2, Qi Liu2

  • 1The Diagnostics Laboratory, Affiliated Hospital to Zunyi Medical University, Zunyi, Guizhou, 563000, People's Republic of China.

概括

染色体组合因子1亚单元A (CHAF1A) 在肝细胞癌 (HCC) 中被上调,与预后不佳和免疫调节相关. 这突出了CHAF1A作为HCC患者的潜在治疗点.